New customers: new education
February 16, 2005Doctors have for a long time been the primary influencers of prescribing and chronic disease management. For pharma companies, that …
NHS to be key election issue as Blair unveils pledge
February 15, 2005Blair, NHS
Tony Blair has signalled Labour’s record on the NHS will be one of the key issues on which it will …
Chronic disease programme needs more work, says think tank
February 14, 2005The new system of chronic disease management currently being piloted in ten PCTs needs further evaluation before it is extended …
New UK biotech fundraising initiative declared a win-win
February 10, 2005Research and Development
Current rules which restrict how companies raise cash should be interpreted more freely to help UK biotech and other hi-tech …
Roche hepatitis and HIV combination approved
February 9, 2005Sales and Marketing
Roche's Pegasys has become the first treatment licensed for patients suffering hepatitis C and HIV at the same time.The European …
Sanofi-Aventis sponsor cardiovascular research centre
February 9, 2005Sales and Marketing
A new UK centre specialising in research into cardiovascular disease has opened its doors at St Mary's Hospital in Paddington, …
Schering launches new dermatology company
February 8, 2005Sales and Marketing
German pharma company Schering has created a new, independent group, Intendis, focused on developing and marketing dermatology products.Intendis' new management …
Audit service launched to judge pharma marketing success
February 8, 2005Marketing consultants Q2 Audit have launched a service to measure pharma's marketing effectiveness and give an indication of future product …
Rare side-effect warnings for Strattera
February 8, 2005Sales and Marketing
UK health professionals have been warned about rare but serious liver problems observed in Lilly's Strattera.The drug has been licensed …
Connecting with patients
February 8, 2005Medical Communications
In order for a clinical trial to be viable, it needs patients. Sounds obvious, but despite the fact that patients …
New depression treatment launched in the UK
February 3, 2005Sales and Marketing
Lilly and Boehringer Ingelheim's depression treatment Cymbalta has been launched in the UK where it will do battle in the …
New ‘economic damage’ offence to beat animal activists
February 3, 2005Sales and Marketing
The government has unveiled new laws to counteract the intimidation tactics used by activists to undermine animal research. Animal rights …
‘Smarter steroid’ Alvesco launched in the UK
February 3, 2005Sales and Marketing
Alvesco, the first one puff, once-daily inhaled corticosteroid for asthma has been launched in the UK, its first European market.Manufacturers …
Aspirin plus PPI better than Plavix in patients with GI bleed
February 2, 2005Sales and Marketing
A new study has concluded that aspirin plus a proton pump inhibitor (PPI) is more effective than Plavix (clopidogrel) in …
BMJ apologises for Prozac accusations
February 2, 2005Sales and Marketing
The BMJ has retracted its allegations that Eli Lilly suppressed important safety information on its antidepressant drug Prozac during litigation …
AstraZeneca remains strong despite setbacks
February 1, 2005Sales and Marketing
AstraZeneca has announced impressive full-year figures for 2004 despite its market value slumping by nearly a third in the past …
Merck hit by US patent blow
February 1, 2005Sales and Marketing
Merck has lost 10 years of US patent protection for the best-selling formulation of its second-biggest selling drug, following a …
Latest content
FibroFind appoints Lee Borthwick as CEO
